LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.26
+0.40 (3.11%)
Apr 20, 2026, 4:08 PM HKT

HKG:2291 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
527.47471.14325.9247.67222.58
Other Revenue
0.470.50.73--
527.94471.64326.62247.67222.58
Revenue Growth (YoY)
11.94%44.40%31.88%11.27%50.14%
Cost of Revenue
80.9947.6137.5327.9825.04
Gross Profit
446.95424.03289.09219.69197.55
Selling, General & Admin
134.92106.7787.571.9170.26
Research & Development
58.1557.9962.0753.8741.39
Other Operating Expenses
-5.22-3.27-7.37-17.74-10.78
Operating Expenses
190.15168.47136.21113.72101.8
Operating Income
256.81255.56152.88105.9795.75
Interest Expense
-0.12-0.16-0.14-18.97-11.55
Interest & Investment Income
23.4828.8425.585.677.85
Currency Exchange Gain (Loss)
-1.96-5.89-82.285.19
Other Non Operating Income (Expenses)
-3.71-0.140.6-0.051.47
EBT Excluding Unusual Items
276.46286.06173.0410.3498.72
Gain (Loss) on Sale of Investments
----4.93-
Gain (Loss) on Sale of Assets
-0.03---
Asset Writedown
----0-0
Other Unusual Items
----20.44-32.69
Pretax Income
276.46286.09173.04-15.0366.03
Income Tax Expense
36.7440.5321.664.787.33
Net Income
239.73245.56151.38-19.8158.7
Net Income to Common
239.73245.56151.38-19.8158.7
Net Income Growth
-2.38%62.22%---14.65%
Shares Outstanding (Basic)
347347347328304
Shares Outstanding (Diluted)
347347347328304
Shares Change (YoY)
--5.86%7.79%9.63%
EPS (Basic)
0.690.710.44-0.060.19
EPS (Diluted)
0.690.710.44-0.060.19
EPS Growth
-2.57%62.22%---22.14%
Free Cash Flow
-137.0566.7552.2582.83
Free Cash Flow Per Share
-0.400.190.160.27
Dividend Per Share
0.5000.6200.570--
Dividend Growth
-19.36%8.77%---
Gross Margin
84.66%89.91%88.51%88.70%88.75%
Operating Margin
48.64%54.19%46.81%42.79%43.02%
Profit Margin
45.41%52.06%46.35%-8.00%26.37%
Free Cash Flow Margin
-29.06%20.44%21.10%37.21%
EBITDA
278.14276.89158.89117.99103.88
EBITDA Margin
52.68%58.71%48.65%47.64%46.67%
D&A For EBITDA
21.3321.336.0112.028.13
EBIT
256.81255.56152.88105.9795.75
EBIT Margin
48.64%54.19%46.81%42.79%43.02%
Effective Tax Rate
13.29%14.17%12.52%-11.10%
Revenue as Reported
527.94471.64326.62--
Advertising Expenses
-3.253.19--
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.